On September 10, 2020 BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, reported that Jonathan Solomon, Chief Executive Officer, will participate in the following upcoming investor conferences (Press release, BiomX, SEP 10, 2020, View Source [SID1234564974]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: HC Wainwright 22nd Annual Global Investments Conference
Date: Monday, Sept. 14, 2020
Time: 12:30 p.m. EDT
Webcast link: View Source

Event: Cantor 2020 Virtual Global Healthcare Conference
Date: Wednesday, Sept. 16, 2020
Time: 11:20 a.m. EDT
Webcast link: View Source

Webcasts will also be available in the Events section of the BiomX website at www.biomx.com. Archived replays will be accessible following each event.